Signalling	O
via	O
CD28	B-protein
of	O
human	B-cell_line
naive	I-cell_line
neonatal	I-cell_line
T	I-cell_line
lymphocytes	I-cell_line
.	O

Accessory	O
molecules	O
play	O
a	O
crucial	O
role	O
in	O
the	O
development	O
of	O
the	O
T	O
cell	O
response	O
to	O
antigenic	O
challenge	O
.	O

We	O
have	O
examined	O
the	O
role	O
of	O
CD28	B-protein
in	O
modulating	O
the	O
'naive	O
'	O
neonatal	O
T	O
cell	O
response	O
to	O
anti-CD2	B-protein
-mediated	O
activation	O
.	O

To	O
compare	O
the	O
role	O
of	O
CD28	B-protein
,	O
neonatal	B-cell_type
and	O
adult	B-cell_type
T	I-cell_type
cells	I-cell_type
were	O
stimulated	O
with	O
a	O
pair	O
of	O
mitogenic	B-protein
anti-CD2	I-protein
antibodies	I-protein
in	O
the	O
presence	O
or	O
absence	O
of	O
anti-CD28	B-protein
MoAb	I-protein
.	O

With	O
anti-CD2	B-protein
alone	O
,	O
neonatal	B-cell_type
T	I-cell_type
cells	I-cell_type
proliferated	O
slightly	O
but	O
produced	O
no	O
detectable	O
IL-2	B-protein
,	O
whereas	O
adult	O
T	B-cell_type
cells	I-cell_type
proliferated	O
vigorously	O
,	O
with	O
significant	O
IL-2	B-protein
production	O
.	O

Costimulation	O
with	O
anti-CD28	B-protein
MoAb	I-protein
greatly	O
enhanced	O
the	O
proliferative	O
response	O
of	O
neonatal	B-cell_type
T	I-cell_type
cells	I-cell_type
to	O
levels	O
equivalent	O
to	O
those	O
of	O
adult	B-cell_type
T	I-cell_type
cells	I-cell_type
,	O
whereas	O
adult	B-cell_type
T	I-cell_type
cells	I-cell_type
showed	O
only	O
slight	O
increases	O
.	O

Although	O
IL-2	B-protein
secretion	O
was	O
increased	O
in	O
the	O
presence	O
of	O
anti-CD28	B-protein
MoAb	I-protein
,	O
neonatal	B-cell_type
T	I-cell_type
cell	I-cell_type
IL-2	B-protein
production	O
remained	O
lower	O
than	O
in	O
adults	O
.	O

In	O
contrast	O
,	O
enhancement	O
of	O
IL-2	B-RNA
mRNA	I-RNA
expression	O
in	O
neonates	O
was	O
similar	O
to	O
adult	O
levels	O
.	O

Anti-	O
CD28	B-protein
MoAb	I-protein
costimulation	O
increased	O
NF	B-protein
kappa	I-protein
B	I-protein
levels	O
in	O
neonates	O
,	O
albeit	O
to	O
levels	O
lower	O
than	O
that	O
of	O
adults	O
.	O

The	O
cellular	O
mechanism	O
governing	O
the	O
diminished	O
proliferative	O
response	O
of	O
neonatal	B-cell_type
T	I-cell_type
lymphocytes	I-cell_type
to	O
anti-CD2	B-protein
may	O
therefore	O
be	O
due	O
to	O
decreased	O
NF	B-protein
kappa	I-protein
B	I-protein
induction	O
,	O
reduced	O
IL-2	B-RNA
mRNA	I-RNA
expression	O
and	O
deficient	O
IL-2	B-protein
production	O
.	O

Although	O
anti-CD28	B-protein
MoAb	I-protein
costimulation	O
enhances	O
all	O
of	O
the	O
above	O
signals	O
,	O
NF	O
kappa	O
B	O
and	O
IL-2	O
levels	O
remain	O
lower	O
than	O
in	O
adults	O
,	O
suggesting	O
the	O
need	O
for	O
further	O
activation	O
requirements	O
in	O
the	O
neonate	O
.	O

Clin	NULL
Exp	NULL
Immunol	NULL
1995	NULL
;	NULL
102:192-198	NULL
Signalling	NULL
via	NULL
CD28	NULL
of	NULL
human	NULL
naive	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
J.	NULL
HASSAN	NULL
,	NULL
$	NULL
.	NULL

O'NEILL	NULL
,	NULL
L.	NULL
A.	NULL
J.	NULL
O'NEILL	NULL
,	NULL
U.	NULL
PATTISON	NULL
&	NULL
D.	NULL
J.	NULL
REEN	NULL
Children	NULL
's	NULL
Research	NULL
Centre	NULL
,	NULL
Our	NULL
Lady	NULL
's	NULL
Hospital	NULL
for	NULL
Sick	NULL
Children	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Biochemistry	NULL
,	NULL
Trinity	NULL
College	NULL
,	NULL
Dublin	NULL
,	NULL
Ireland	NULL
(	NULL
Accepted	NULL
for	NULL
publication	NULL
23	NULL
June	NULL
1995	NULL
)	NULL
sUMMARY	NULL
Accessory	NULL
molecules	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
antigenic	NULL
challenge	NULL
.	NULL

We	NULL
have	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
CD28	NULL
in	NULL
modulating	NULL
the	NULL
'naive	NULL
'	NULL
neonatal	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
anti-CD2-mediated	NULL
activation	NULL
.	NULL

To	NULL
compare	NULL
the	NULL
role	NULL
of	NULL
CD28	NULL
,	NULL
neonatal	NULL
and	NULL
adult	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
a	NULL
pair	NULL
of	NULL
mitogenic	NULL
anti-CD2	NULL
antibodies	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
.	NULL

With	NULL
anti-CD2	NULL
alone	NULL
,	NULL
neonatal	NULL
T	NULL
cells	NULL
proliferated	NULL
slightly	NULL
but	NULL
produced	NULL
no	NULL
detectable	NULL
IL-2	NULL
,	NULL
whereas	NULL
adult	NULL
T	NULL
cells	NULL
proliferated	NULL
vigorously	NULL
,	NULL
with	NULL
significant	NULL
IL-2	NULL
production	NULL
.	NULL

Costimulation	NULL
with	NULL
anti-CD28	NULL
MoAb	NULL
greatly	NULL
enhanced	NULL
the	NULL
proliferative	NULL
response	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
to	NULL
levels	NULL
equivalent	NULL
to	NULL
those	NULL
of	NULL
adult	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
adult	NULL
T	NULL
cells	NULL
showed	NULL
only	NULL
slight	NULL
increases	NULL
.	NULL

Although	NULL
IL-2	NULL
secretion	NULL
was	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
,	NULL
neonatal	NULL
T	NULL
cell	NULL
IL-2	NULL
production	NULL
remained	NULL
lower	NULL
than	NULL
in	NULL
adults	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
enhancement	NULL
of	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
in	NULL
neonates	NULL
was	NULL
similar	NULL
to	NULL
adult	NULL
levels	NULL
.	NULL

Anti-CD28	NULL
MoAb	NULL
costimulation	NULL
increased	NULL
NFB	NULL
levels	NULL
in	NULL
neonates	NULL
,	NULL
albeit	NULL
to	NULL
levels	NULL
lower	NULL
than	NULL
that	NULL
of	NULL
adults	NULL
.	NULL

The	NULL
cellular	NULL
mechanism	NULL
governing	NULL
the	NULL
diminished	NULL
proliferative	NULL
response	NULL
of	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
to	NULL
anti-CD2	NULL
may	NULL
therefore	NULL
be	NULL
due	NULL
to	NULL
decreased	NULL
NFxB	NULL
induction	NULL
,	NULL
reduced	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
and	NULL
deficient	NULL
IL-2	NULL
production	NULL
.	NULL

Although	NULL
anti-CD28	NULL
MoAb	NULL
costimulation	NULL
enhances	NULL
all	NULL
of	NULL
the	NULL
above	NULL
signals	NULL
,	NULL
NFB	NULL
and	NULL
IL-2	NULL
levels	NULL
remain	NULL
lower	NULL
than	NULL
in	NULL
adults	NULL
,	NULL
suggesting	NULL
the	NULL
need	NULL
for	NULL
further	NULL
activation	NULL
requirements	NULL
in	NULL
the	NULL
neonate	NULL
.	NULL

Keywords	NULL
neonatal	NULL
T	NULL
cells	NULL
CD28	NULL
INTRODUCTION	NULL
The	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
an	NULL
effective	NULL
immune	NULL
response	NULL
,	NULL
and	NULL
requires	NULL
the	NULL
occupancy	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
by	NULL
foreign	NULL
antigen	NULL
complexed	NULL
with	NULL
self-MHC	NULL
as	NULL
well	NULL
as	NULL
an	NULL
additional	NULL
signal	NULL
delivered	NULL
by	NULL
antigen-presenting	NULL
cells	NULL
(	NULL
APC	NULL
)	NULL
[	NULL
1	NULL
]	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
costimulation	NULL
during	NULL
TCR	NULL
engagement	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
antigen-specific	NULL
tolerance	NULL
or	NULL
anergy	NULL
[	NULL
1	NULL
]	NULL
or	NULL
possibly	NULL
apoptosis	NULL
[	NULL
2	NULL
]	NULL
.	NULL

One	NULL
of	NULL
the	NULL
most	NULL
studied	NULL
of	NULL
these	NULL
costimulatory	NULL
molecules	NULL
is	NULL
CD28	NULL
,	NULL
a	NULL
44-kD	NULL
glycoprotein	NULL
member	NULL
of	NULL
the	NULL
immunoglobulin	NULL
superfamily	NULL
[	NULL
3	NULL
]	NULL
.	NULL

CD28	NULL
is	NULL
expressed	NULL
by	NULL
virtually	NULL
all	NULL
CD4*	NULL
T	NULL
cells	NULL
and	NULL
~	NULL
50	NULL
%	NULL
of	NULL
human	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
.	NULL

Treatment	NULL
of	NULL
mitogen	NULL
or	NULL
anti-TCR-stimulated	NULL
T	NULL
cells	NULL
with	NULL
MoAbs	NULL
directed	NULL
against	NULL
CD28	NULL
induces	NULL
a	NULL
substantial	NULL
increase	NULL
in	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
primarily	NULL
due	NULL
to	NULL
an	NULL
increase	NULL
in	NULL
IL-2	NULL
synthesis	NULL
[	NULL
4	NULL
]	NULL
.	NULL

This	NULL
super-induction	NULL
of	NULL
IL-2	NULL
production	NULL
involves	NULL
two	NULL
mechanisms	NULL
:	NULL
stabilization	NULL
of	NULL
IL-2	NULL
mRNA	NULL
[	NULL
5,6	NULL
]	NULL
,	NULL
and	NULL
enhanced	NULL
gene	NULL
transcription	NULL
mediated	NULL
at	NULL
least	NULL
in	NULL
part	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
NFxB	NULL
,	NULL
by	NULL
CD28	NULL
[	NULL
7,8	NULL
]	NULL
.	NULL

NFKB	NULL
is	NULL
a	NULL
key	NULL
regulator	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
IL-2	NULL
up-regulation	NULL
,	NULL
CD28	NULL
signal	NULL
transduction	NULL
also	NULL
increases	NULL
the	NULL
mRNA	NULL
and	NULL
secretion	NULL
of	NULL
several	NULL
Correspondence	NULL
:	NULL
Dr	NULL
Jaythoon	NULL
Hassan	NULL
,	NULL
Children	NULL
's	NULL
Research	NULL
Centre	NULL
,	NULL
Our	NULL
Lady	NULL
's	NULL
Hospital	NULL
for	NULL
Sick	NULL
Children	NULL
,	NULL
Crumlin	NULL
,	NULL
Dublin	NULL
12	NULL
,	NULL
Ireland	NULL
.	NULL

192	NULL
IL-2	NULL
mRNA	NULL
-	NULL
NFkB	NULL
other	NULL
T	NULL
cell-expressed	NULL
cytokines	NULL
,	NULL
including	NULL
granulocyte-macro-phage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
IL-3	NULL
,	NULL
tumour	NULL
necrosis	NULL
factor-alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
and	NULL
TNF-	NULL
[	NULL
9	NULL
]	NULL
.	NULL

With	NULL
regard	NULL
to	NULL
IL-2	NULL
production	NULL
in	NULL
the	NULL
neonate	NULL
,	NULL
increased	NULL
[	NULL
10	NULL
]	NULL
,	NULL
normal	NULL
[	NULL
11	NULL
]	NULL
or	NULL
reduced	NULL
[	NULL
12,13	NULL
]	NULL
,	NULL
secretion	NULL
have	NULL
been	NULL
reported	NULL
[	NULL
10-13	NULL
]	NULL
.	NULL

These	NULL
differences	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
use	NULL
of	NULL
different	NULL
types	NULL
of	NULL
stimulating	NULL
agents	NULL
which	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
distinct	NULL
patterns	NULL
of	NULL
cytokine	NULL
production	NULL
[	NULL
14	NULL
]	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
report	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
the	NULL
diminished	NULL
proliferative	NULL
response	NULL
to	NULL
anti-CD2	NULL
antibodies	NULL
was	NULL
paralleled	NULL
by	NULL
reduced	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
[	NULL
15	NULL
]	NULL
.	NULL

This	NULL
deficient	NULL
response	NULL
by	NULL
neonatal	NULL
T	NULL
cells	NULL
may	NULL
represent	NULL
true	NULL
functional	NULL
immaturity	NULL
,	NULL
but	NULL
may	NULL
also	NULL
suggest	NULL
that	NULL
signalling	NULL
through	NULL
specific	NULL
antigen	NULL
receptors	NULL
in	NULL
the	NULL
neonate	NULL
may	NULL
be	NULL
dependent	NULL
on	NULL
costimulatory	NULL
interactions	NULL
for	NULL
generation	NULL
of	NULL
an	NULL
appropriate	NULL
response	NULL
.	NULL

Since	NULL
a	NULL
signal	NULL
delivered	NULL
by	NULL
the	NULL
CD28	NULL
molecule	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
reverse	NULL
anergy	NULL
[	NULL
16	NULL
]	NULL
,	NULL
we	NULL
addressed	NULL
the	NULL
question	NULL
whether	NULL
costimulation	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
via	NULL
CD28	NULL
could	NULL
serve	NULL
as	NULL
a	NULL
second	NULL
signal	NULL
to	NULL
prevent	NULL
the	NULL
anti-CD2-induced	NULL
hyporesponsiveness	NULL
of	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
strongly	NULL
suggest	NULL
that	NULL
signalling	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
via	NULL
CD28	NULL
reverses	NULL
the	NULL
hyporesponsiveness	NULL
to	NULL
anti-CD2	NULL
antibodies	NULL
and	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
expansion	NULL
and	NULL
generation	NULL
of	NULL
the	NULL
neonatal	NULL
immune	NULL
response	NULL
.	NULL

©	NULL
1995	NULL
Blackwell	NULL
Science	NULL
CD28	NULL
signalling	NULL
of	NULL
human	NULL
naive	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
193	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Monoclonal	NULL
antibodies	NULL
Anti-CD2	NULL
antibodies	NULL
ACD2M	NULL
1	NULL
and	NULL
ACD2M2	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
Dr	NULL
Stefan	NULL
Meuer	NULL
(	NULL
Deutsches	NULL
Krebforschungszentrum	NULL
,	NULL
Heidel-berg	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
and	NULL
are	NULL
known	NULL
to	NULL
be	NULL
mitogenic	NULL
and	NULL
accessory	NULL
cell-independent	NULL
[	NULL
17	NULL
]	NULL
.	NULL

Anti-CD28	NULL
MoAb	NULL
(	NULL
9.3	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Bristol-Myers	NULL
Squibb	NULL
Pharmaceutical	NULL
Research	NULL
Institute	NULL
(	NULL
Seat-tle	NULL
,	NULL
WA	NULL
)	NULL
.	NULL

Isotype	NULL
control	NULL
antibodies	NULL
used	NULL
were	NULL
FITC-IgG1	NULL
and	NULL
PE-IgG2	NULL
(	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Oxford	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Cell	NULL
preparation	NULL
Cord	NULL
blood	NULL
was	NULL
collected	NULL
from	NULL
the	NULL
umbilical	NULL
vein	NULL
,	NULL
immediately	NULL
after	NULL
delivery	NULL
,	NULL
in	NULL
uncomplicated	NULL
pregnancies	NULL
at	NULL
term	NULL
(	NULL
mean	NULL
gestation	NULL
=	NULL
40	NULL
weeks	NULL
,	NULL
range	NULL
38-41	NULL
weeks	NULL
)	NULL
.	NULL

Venous	NULL
peripheral	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
healthy	NULL
adult	NULL
volunteers	NULL
.	NULL

Mononuclear	NULL
cells	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Hypaque	NULL
(	NULL
Lymphoprep	NULL
,	NULL
Nycomed	NULL
,	NULL
Norway	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
and	NULL
resuspended	NULL
in	NULL
complete	NULL
culture	NULL
medium	NULL
.	NULL

T	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
two	NULL
passages	NULL
through	NULL
nylon	NULL
wool	NULL
(	NULL
Poly	NULL
Sciences	NULL
,	NULL
Northamp-ton	NULL
,	NULL
UK	NULL
)	NULL
columns	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Julius	NULL
et	NULL
a/	NULL
.	NULL

[	NULL
18	NULL
]	NULL
.	NULL

FACScan	NULL
analysis	NULL
revealed	NULL
these	NULL
cells	NULL
to	NULL
be	NULL
>	NULL
95	NULL
%	NULL
CD3	NULL
*	NULL
,	NULL
<	NULL
1	NULL
%	NULL
CD19*	NULL
,	NULL
<	NULL
1	NULL
%	NULL
CD14*	NULL
,	NULL
and	NULL
they	NULL
were	NULL
considered	NULL
to	NULL
be	NULL
purified	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
proliferation	NULL
assay	NULL
All	NULL
cell	NULL
cultures	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Gisco	NULL
,	NULL
Paisley	NULL
,	NULL
UK	NULL
)	NULL
supplemented	NULL
with	NULL
L-glutamine	NULL
(	NULL
2	NULL
mm	NULL
)	NULL
,	NULL
gentamycin	NULL
(	NULL
50	NULL
ug/ml	NULL
)	NULL
,	NULL
fungizone	NULL
(	NULL
2	NULL
pg/ml	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

T	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°/well	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
triplicate	NULL
in	NULL
96-well	NULL
flat-bottomed	NULL
microtitre	NULL
plates	NULL
(	NULL
Nunc	NULL
,	NULL
Roskilde	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

Cell	NULL
proliferation	NULL
was	NULL
obtained	NULL
by	NULL
adding	NULL
the	NULL
combination	NULL
of	NULL
anti-CD2	NULL
antibodies	NULL
at	NULL
0-25	NULL
ug/ml	NULL
final	NULL
concentration	NULL
.	NULL

Anti-CD28	NULL
MoAb	NULL
was	NULL
used	NULL
at	NULL
1:1000	NULL
dilution	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
humidified	NULL
atmosphere	NULL
at	NULL
37°C	NULL
for	NULL
72	NULL
h.	NULL
Cell	NULL
proliferation	NULL
was	NULL
measured	NULL
by	NULL
°H-thymidine	NULL
incorporation	NULL
(	NULL
0-3	NULL
Ci	NULL
;	NULL
sp	NULL
.	NULL

act	NULL
.	NULL

25	NULL
Ci/mmol	NULL
;	NULL
Amersham	NULL
,	NULL
Aylesbury	NULL
,	NULL
UK	NULL
)	NULL
during	NULL
the	NULL
last	NULL
18	NULL
h	NULL
of	NULL
culture	NULL
and	NULL
counted	NULL
in	NULL
a	NULL
liquid	NULL
scintillation	NULL
counter	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
ct/min	NULL
°H-thymidine	NULL
incorporation	NULL
.	NULL

IL-2	NULL
production	NULL
T	NULL
cell	NULL
cultures	NULL
were	NULL
set	NULL
up	NULL
in	NULL
l-ml	NULL
volumes	NULL
.	NULL

After	NULL
24	NULL
h	NULL
,	NULL
cells	NULL
were	NULL
pelleted	NULL
.	NULL

Supernatants	NULL
were	NULL
stored	NULL
at	NULL
-20°C	NULL
until	NULL
IL-2	NULL
levels	NULL
were	NULL
measured	NULL
using	NULL
a	NULL
CTLL	NULL
IL-2-dependent	NULL
cell	NULL
line	NULL
.	NULL

Recombinant	NULL
human	NULL
IL-2	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
was	NULL
used	NULL
as	NULL
reference	NULL
standard	NULL
for	NULL
the	NULL
IL-2	NULL
bioassay	NULL
.	NULL

RNA	NULL
extraction	NULL
and	NULL
dot	NULL
blot	NULL
analysis	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
18	NULL
h.	NULL
Cytoplasmic	NULL
lysates	NULL
were	NULL
prepared	NULL
for	NULL
mRNA	NULL
analysis	NULL
as	NULL
previously	NULL
described	NULL
[	NULL
19	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
pelleted	NULL
and	NULL
washed	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
cell	NULL
pellets	NULL
were	NULL
lysed	NULL
for	NULL
5	NULL
min	NULL
in	NULL
200	NULL
ul	NULL
of	NULL
lysis	NULL
buffer	NULL
containing	NULL
140	NULL
mm	NULL
NaCl	NULL
,	NULL
1-5	NULL
mm	NULL
MgCl	NULL
,	NULL
10	NULL
mm	NULL
Tris-HCl	NULL
pH	NULL
86	NULL
,	NULL
1	NULL
mm	NULL
DTT	NULL
,	NULL
placental	NULL
RNAase	NULL
inhibitor	NULL
(	NULL
1000	NULL
U/ml	NULL
)	NULL
and	NULL
0:5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

The	NULL
cell	NULL
nuclei	NULL
were	NULL
pelleted	NULL
and	NULL
the	NULL
supernatants	NULL
transferred	NULL
to	NULL
a	NULL
fresh	NULL
tube	NULL
.	NULL

Two-hundred	NULL
microlitres	NULL
of	NULL
proteinase	NULL
K	NULL
digestion	NULL
buffer	NULL
(	NULL
0:2	NULL
m	NULL
Tris-HCl	NULL
pH	NULL
8:0	NULL
,	NULL
25	NULL
mm	NULL
EDTA	NULL
pH	NULL
8:0	NULL
,	NULL
0-3	NULL
m	NULL
NaCl	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
)	NULL
and	NULL
proteinase	NULL
K	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
50	NULL
ug/ml	NULL
were	NULL
added	NULL
,	NULL
mixed	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Two	NULL
cycles	NULL
of	NULL
phenol	NULL
:	NULL
chloroform	NULL
extraction	NULL
and	NULL
one	NULL
cycle	NULL
of	NULL
chloroform	NULL
:	NULL
isoamylaleohol	NULL
extraction	NULL
were	NULL
performed	NULL
.	NULL

RNA	NULL
was	NULL
precipitated	NULL
with	NULL
0-3	NULL
m	NULL
sodium	NULL
acetate	NULL
pH	NULL
5-2	NULL
(	NULL
final	NULL
concentration	NULL
)	NULL
and	NULL
2:5	NULL
volumes	NULL
of	NULL
ice-cold	NULL
ethanol	NULL
and	NULL
stored	NULL
at	NULL
~70°C	NULL
until	NULL
use	NULL
.	NULL

To	NULL
recover	NULL
the	NULL
RNA	NULL
,	NULL
samples	NULL
were	NULL
centrifuged	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
at	NULL
9000	NULL
g	NULL
,	NULL
the	NULL
ethanol	NULL
removed	NULL
and	NULL
the	NULL
RNA	NULL
resuspended	NULL
in	NULL
10	NULL
ul	NULL
DEPC-treated	NULL
H	NULL
;	NULL
,	NULL
O.	NULL
RNA	NULL
was	NULL
pretreated	NULL
at	NULL
68°C	NULL
for	NULL
15	NULL
min	NULL
with	NULL
20	NULL
ul	NULL
formamide	NULL
,	NULL
7	NULL
ul	NULL
formaldehyde	NULL
and	NULL
2	NULL
pul	NULL
20	NULL
x	NULL
SSC	NULL
.	NULL

Eighty	NULL
microlitres	NULL
of	NULL
20	NULL
x	NULL
SSC	NULL
were	NULL
added	NULL
to	NULL
the	NULL
RNA	NULL
and	NULL
samples	NULL
were	NULL
applied	NULL
onto	NULL
Hybond	NULL
N	NULL
+	NULL
nylon	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
using	NULL
a	NULL
slot	NULL
blot	NULL
manifold	NULL
and	NULL
the	NULL
membrane	NULL
was	NULL
then	NULL
baked	NULL
for	NULL
2	NULL
h	NULL
at	NULL
80°C	NULL
.	NULL

Pre-hybridization	NULL
was	NULL
performed	NULL
in	NULL
5	NULL
ml	NULL
of	NULL
gold	NULL
hybridization	NULL
buffer	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Amersham	NULL
)	NULL
at	NULL
42°C	NULL
for	NULL
2	NULL
h.	NULL
Gel-purified	NULL
cDNA	NULL
probes	NULL
for	NULL
IL-2	NULL
(	NULL
ATCC	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
and	NULL
A-actin	NULL
were	NULL
labelled	NULL
with	NULL
horseradish	NULL
peroxidase	NULL
using	NULL
the	NULL
direct	NULL
labelling	NULL
procedure	NULL
of	NULL
the	NULL
Enhanced	NULL
Chemiluminescence	NULL
Kit	NULL
(	NULL
Amer-sham	NULL
)	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
at	NULL
42°C	NULL
for	NULL
16	NULL
h.	NULL
Stringency	NULL
washes	NULL
were	NULL
performed	NULL
at	NULL
42°C	NULL
with	NULL
two	NULL
20-min	NULL
washes	NULL
with	NULL
0-5	NULL
x	NULL
SSC	NULL
,	NULL
0:4	NULL
%	NULL
SDS	NULL
,	NULL
6	NULL
m	NULL
urea	NULL
followed	NULL
by	NULL
a	NULL
further	NULL
two	NULL
10-min	NULL
washes	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
2	NULL
x	NULL
SSC	NULL
.	NULL

Hybridization	NULL
was	NULL
assessed	NULL
by	NULL
chemiluminescence	NULL
and	NULL
autoradiography	NULL
and	NULL
slot	NULL
blots	NULL
were	NULL
analysed	NULL
by	NULL
densitometry	NULL
.	NULL

Adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
and	NULL
processed	NULL
in	NULL
parallel	NULL
in	NULL
each	NULL
experi-ment	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
unstimulated	NULL
)	NULL
,	NULL
anti-CD2	NULL
MoAbs	NULL
,	NULL
anti-CD2	NULL
+	NULL
anti-CD28	NULL
MoAbs	NULL
or	NULL
anti-CD28	NULL
MoAb	NULL
alone	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
procedure	NULL
of	NULL
Osborn	NULL
et	NULL
a/	NULL
.	NULL

[	NULL
20	NULL
]	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
cold	NULL
PBS	NULL
followed	NULL
by	NULL
washing	NULL
in	NULL
Buffer	NULL
A	NULL
(	NULL
containing	NULL
10	NULL
mm	NULL
HEPES	NULL
pH	NULL
79	NULL
,	NULL
1:5	NULL
mm	NULL
MgCl	NULL
,	NULL
10	NULL
mm	NULL
KCL	NULL
,	NULL
0-5	NULL
mm	NULL
PMSF	NULL
and	NULL
0-5	NULL
mm	NULL
DTT	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
20	NULL
ul	NULL
Buffer	NULL
A	NULL
containing	NULL
01	NULL
%	NULL
NP40	NULL
and	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
.	NULL

Following	NULL
centrifugation	NULL
at	NULL
9000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
the	NULL
pellets	NULL
were	NULL
resuspended	NULL
in	NULL
15	NULL
pul	NULL
buffer	NULL
containing	NULL
20	NULL
mm	NULL
HEPES	NULL
pH	NULL
7-9	NULL
,	NULL
420	NULL
mm	NULL
NaCl	NULL
,	NULL
1:5	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
02	NULL
mm	NULL
EDTA	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
and	NULL
0:5	NULL
mm	NULL
PMSF	NULL
and	NULL
placed	NULL
on	NULL
ice	NULL
for	NULL
15	NULL
min	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
supernatant	NULL
was	NULL
transferred	NULL
to	NULL
a	NULL
clean	NULL
tube	NULL
and	NULL
75	NULL
pl	NULL
of	NULL
buffer	NULL
containing	NULL
10	NULL
mm	NULL
HEPES	NULL
pH	NULL
7-9	NULL
,	NULL
50	NULL
mm	NULL
KCl	NULL
,	NULL
02	NULL
mm	NULL
EDTA	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0-5	NULL
mm	NULL
PMSF	NULL
,	NULL
0-5	NULL
mm	NULL
DTT	NULL
were	NULL
added	NULL
.	NULL

Protein	NULL
concentration	NULL
was	NULL
determined	NULL
using	NULL
the	NULL
Bradford	NULL
assay	NULL
(	NULL
BioRad	NULL
,	NULL
Hemel	NULL
Hempstead	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Electrophoretic-mobility-shift	NULL
assay	NULL
Nuclear	NULL
extracts	NULL
(	NULL
1	NULL
ug	NULL
of	NULL
protein	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
10	NULL
000	NULL
ct/min	NULL
of	NULL
a	NULL
22	NULL
bp	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
sequence	NULL
which	NULL
had	NULL
been	NULL
previously	NULL
labelled	NULL
with	NULL
y-*°P-ATP	NULL
(	NULL
10	NULL
mCi/mmol	NULL
)	NULL
by	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
[	NULL
21	NULL
]	NULL
.	NULL

Incuba-tions	NULL
were	NULL
performed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
100	NULL
mm	NULL
Tris-HCl	NULL
buffer	NULL
pH	NULL
7-5	NULL
,	NULL
containing	NULL
1	NULL
m	NULL
NaCl	NULL
,	NULL
10	NULL
mm	NULL
EDTA	NULL
,	NULL
50	NULL
mm	NULL
DTT	NULL
,	NULL
40	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
glycerol	NULL
and	NULL
1	NULL
mg/ml	NULL
nuclease-free	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
.	NULL

All	NULL
incubation	NULL
mixtures	NULL
were	NULL
subjected	NULL
to	NULL
electrophor-esis	NULL
on	NULL
native	NULL
4	NULL
%	NULL
(	NULL
w/v	NULL
)	NULL
polyacrylamide	NULL
gels	NULL
which	NULL
were	NULL
subsequently	NULL
dried	NULL
and	NULL
autoradiographed	NULL
.	NULL

Statistical	NULL
analysis	NULL
Results	NULL
of	NULL
slot	NULL
blots	NULL
are	NULL
expressed	NULL
as	NULL
arbitrary	NULL
units	NULL
obtained	NULL
by	NULL
©	NULL
1995	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
102:192-198	NULL
194	NULL
J.	NULL
Hassan	NULL
et	NULL
al	NULL
.	NULL

100	NULL
80	NULL
|-	NULL
ct/min	NULL
x	NULL
10°	NULL
EEE	NULL
EEE	NULL
%	NULL
°	NULL
&	NULL
8	NULL
%	NULL
°	NULL
&	NULL
8	NULL
C	NULL
a	NULL
[	NULL
<	NULL
a	NULL
3	NULL
_	NULL
,	NULL
0	NULL
s	NULL
_	NULL
,	NULL
0	NULL
AD-T	NULL
CB-T	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
on	NULL
the	NULL
response	NULL
of	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
to	NULL
anti-CD2	NULL
stimulation	NULL
.	NULL

T	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/well	NULL
)	NULL
were	NULL
unstimulated	NULL
or	NULL
stimulated	NULL
with	NULL
anti-CD2	NULL
alone	NULL
,	NULL
anti-CD2	NULL
+	NULL
anti-CD28	NULL
MoAb	NULL
or	NULL
anti-CD28	NULL
MoAb	NULL
alone	NULL
.	NULL

Proliferation	NULL
was	NULL
assessed	NULL
by	NULL
incorporation	NULL
for	NULL
the	NULL
last	NULL
18	NULL
h	NULL
of	NULL
72	NULL
h	NULL
cultures	NULL
and	NULL
is	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
of	NULL
triplicate	NULL
cultures	NULL
.	NULL

Data	NULL
are	NULL
represented	NULL
as	NULL
mean	NULL
+	NULL
s.e.m	NULL
.	NULL

of	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

AD	NULL
,	NULL
Adult	NULL
;	NULL
CB	NULL
,	NULL
cord	NULL
blood	NULL
.	NULL

measuring	NULL
peak	NULL
heights	NULL
on	NULL
densitometric	NULL
scans	NULL
.	NULL

Statistical	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
Wilcoxon	NULL
rank	NULL
test	NULL
for	NULL
non-parametric	NULL
data	NULL
.	NULL

RESULTS	NULL
Costimulation	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
with	NULL
anti-CD28	NULL
MoAb	NULL
We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
proliferative	NULL
responses	NULL
of	NULL
purified	NULL
cord	NULL
T	NULL
cells	NULL
to	NULL
anti-CD2	NULL
stimulation	NULL
results	NULL
in	NULL
reduced	NULL
responses	NULL
compared	NULL
with	NULL
adult	NULL
T	NULL
cells	NULL
[	NULL
15	NULL
]	NULL
.	NULL

Using	NULL
this	NULL
system	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
ability	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
to	NULL
provide	NULL
a	NULL
costimulatory	NULL
requirement	NULL
in	NULL
cultures	NULL
of	NULL
purified	NULL
T	NULL
cells	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
that	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
in	NULL
anti-CD2-stimulated	NULL
neonatal	NULL
T	NULL
cell	NULL
cultures	NULL
resulted	NULL
in	NULL
markedly	NULL
enhanced	NULL
proliferation	NULL
(	NULL
from	NULL
6754	NULL
+2298	NULL
ct/min	NULL
to	NULL
57	NULL
460	NULL
+	NULL
16	NULL
129	NULL
ct/min	NULL
;	NULL
P	NULL
<	NULL
0-001	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
adult	NULL
T	NULL
cell	NULL
cultures	NULL
further	NULL
enhancement	NULL
of	NULL
proliferation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
,	NULL
although	NULL
significant	NULL
(	NULL
P	NULL
<	NULL
0:03	NULL
)	NULL
,	NULL
was	NULL
modest	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
a	NULL
previous	NULL
report	NULL
[	NULL
9	NULL
]	NULL
which	NULL
showed	NULL
no	NULL
enhancement	NULL
of	NULL
T	NULL
cell	NULL
proliferation	NULL
as	NULL
a	NULL
20	NULL
IL-2	NULL
(	NULL
U/mi1	NULL
)	NULL
Unstim	NULL
.	NULL

CD28	NULL
Unstim	NULL
.	NULL

CD2	NULL
CD28	NULL
-|	NULL
Chairs	NULL
o	NULL
®	NULL
|-	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
on	NULL
IL-2	NULL
production	NULL
of	NULL
adult	NULL
and	NULL
neonatal	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD2	NULL
antibodies	NULL
.	NULL

Supernatants	NULL
for	NULL
the	NULL
measurement	NULL
of	NULL
IL-2	NULL
production	NULL
were	NULL
removed	NULL
after	NULL
24	NULL
h	NULL
of	NULL
incubation	NULL
and	NULL
assayed	NULL
in	NULL
the	NULL
CTLL	NULL
assay	NULL
.	NULL

Data	NULL
show	NULL
the	NULL
results	NULL
of	NULL
four	NULL
separate	NULL
experiments	NULL
and	NULL
are	NULL
represented	NULL
as	NULL
mean	NULL
+	NULL
s.e.m	NULL
.	NULL

AD	NULL
,	NULL
Adult	NULL
;	NULL
CB	NULL
,	NULL
cord	NULL
blood	NULL
.	NULL

result	NULL
of	NULL
anti-CD28	NULL
costimulation	NULL
when	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
optimal	NULL
concentrations	NULL
of	NULL
immobilized	NULL
anti-CD3	NULL
MoAb	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
in	NULL
combination	NULL
with	NULL
anti-CD2	NULL
to	NULL
neonatal	NULL
T	NULL
cells	NULL
restored	NULL
the	NULL
proliferative	NULL
response	NULL
to	NULL
adult	NULL
T	NULL
cell	NULL
levels	NULL
.	NULL

Unstimulated	NULL
cultures	NULL
or	NULL
cultures	NULL
with	NULL
anti-CD28	NULL
MoAb	NULL
alone	NULL
showed	NULL
no	NULL
thymidine	NULL
uptake	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
on	NULL
IL-2	NULL
secretion	NULL
Costimulation	NULL
with	NULL
anti-CD28	NULL
MoAb	NULL
has	NULL
been	NULL
documented	NULL
to	NULL
enhance	NULL
IL-2	NULL
production	NULL
by	NULL
human	NULL
T	NULL
cells	NULL
[	NULL
9	NULL
]	NULL
.	NULL

Addition	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
to	NULL
anti-CD2-stimulated	NULL
adult	NULL
and	NULL
neonatal	NULL
T	NULL
cells	NULL
resulted	NULL
in	NULL
markedly	NULL
enhanced	NULL
IL-2	NULL
secretion	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
IL-2	NULL
production	NULL
by	NULL
adult	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CD2	NULL
and	NULL
CD2	NULL
+	NULL
CD28	NULL
was	NULL
significantly	NULL
greater	NULL
than	NULL
IL-2	NULL
levels	NULL
produced	NULL
by	NULL
similarly	NULL
stimulated	NULL
neonatal	NULL
T	NULL
cells	NULL
(	NULL
P	NULL
<	NULL
0-01	NULL
;	NULL
P	NULL
<	NULL
0-02	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
was	NULL
noted	NULL
that	NULL
when	NULL
adult	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-CD2	NULL
plus	NULL
anti-CD28	NULL
,	NULL
there	NULL
was	NULL
a	NULL
substantial	NULL
augmentation	NULL
in	NULL
the	NULL
secretion	NULL
of	NULL
IL-2	NULL
,	NULL
yet	NULL
the	NULL
proliferative	NULL
response	NULL
was	NULL
only	NULL
modestly	NULL
increased	NULL
.	NULL

These	NULL
findings	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
those	NULL
of	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

[	NULL
9	NULL
]	NULL
,	NULL
who	NULL
showed	NULL
no	NULL
increase	NULL
in	NULL
thymidine	NULL
,	NULL
yet	NULL
a	NULL
5-50-fold	NULL
©	NULL
1995	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
102:192-198	NULL
CD28	NULL
signalling	NULL
of	NULL
human	NULL
naive	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
195	NULL
160	NULL
|-150	NULL
140	NULL
130	NULL
120	NULL
110	NULL
100	NULL
90	NULL
80	NULL
70	NULL
60	NULL
50	NULL
40	NULL
30	NULL
20	NULL
10	NULL
ct/min	NULL
x	NULL
10°	NULL
CD2	NULL
Unstim	NULL
.	NULL

CD2	NULL
I	NULL
Unstim	NULL
.	NULL

CD2+1L-2	NULL
CD2+IL-2	NULL
AD-T	NULL
CB-T	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Influence	NULL
of	NULL
exogenous	NULL
IL-2	NULL
(	NULL
25	NULL
U	NULL
ml	NULL
)	NULL
on	NULL
anti-CD2-activated	NULL
neonatal	NULL
and	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

Proliferation	NULL
was	NULL
assessed	NULL
by	NULL
*H-thymidine	NULL
incorporation	NULL
for	NULL
the	NULL
last	NULL
18	NULL
h	NULL
of	NULL
72	NULL
h	NULL
cultures	NULL
and	NULL
are	NULL
the	NULL
means	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL

Data	NULL
are	NULL
represented	NULL
as	NULL
the	NULL
mean	NULL
£	NULL
s.e.m	NULL
.	NULL

of	NULL
seven	NULL
adults	NULL
and	NULL
seven	NULL
neonates	NULL
studied	NULL
.	NULL

AD	NULL
.	NULL

Adult	NULL
:	NULL
CB	NULL
.	NULL

cord	NULL
blood	NULL
.	NULL

enhancement	NULL
of	NULL
IL-2	NULL
secretion	NULL
in	NULL
adult	NULL
T	NULL
cells	NULL
costimulated	NULL
with	NULL
anti-CD3	NULL
and	NULL
anti-C	NULL
D28	NULL
MoAbs	NULL
was	NULL
observed	NULL
.	NULL

The	NULL
mean	NULL
fold	NULL
enhancement	NULL
of	NULL
IL-2	NULL
production	NULL
induced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
was	NULL
much	NULL
greater	NULL
in	NULL
neonatal	NULL
T	NULL
cell	NULL
cultures	NULL
(	NULL
26-8-fold	NULL
)	NULL
compared	NULL
with	NULL
adult	NULL
cultures	NULL
(	NULL
6-8-fold	NULL
)	NULL
.	NULL

Cultures	NULL
containing	NULL
anti-CD28	NULL
MoAb	NULL
alone	NULL
did	NULL
not	NULL
result	NULL
in	NULL
IL-2	NULL
production	NULL
in	NULL
any	NULL
of	NULL
the	NULL
samples	NULL
studied	NULL
.	NULL

Effect	NULL
of	NULL
exogenous	NULL
IL-2	NULL
on	NULL
anti-CD2-mediated	NULL
activation	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
Because	NULL
endogenous	NULL
IL-2	NULL
production	NULL
by	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
activated	NULL
with	NULL
anti-CD2	NULL
alone	NULL
was	NULL
low	NULL
.	NULL

the	NULL
effect	NULL
of	NULL
exogenous	NULL
IL-2	NULL
(	NULL
5	NULL
U	NULL
well	NULL
)	NULL
on	NULL
these	NULL
cultures	NULL
was	NULL
examined	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Neonatal	NULL
T	NULL
cells	NULL
showed	NULL
significantly	NULL
greater	NULL
increases	NULL
in	NULL
proliferation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
exogenous	NULL
IL-2	NULL
compared	NULL
with	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
.	NULL

the	NULL
percentage	NULL
increase	NULL
in	NULL
proliferative	NULL
response	NULL
of	NULL
newborns	NULL
was	NULL
significantly	NULL
greater	NULL
than	NULL
in	NULL
adults	NULL
(	NULL
mean	NULL
per	NULL
cent	NULL
increase	NULL
+	NULL
s.e.m	NULL
.	NULL

:	NULL
newborns	NULL
.	NULL

1374	NULL
+	NULL
440	NULL
%	NULL
:	NULL
adults	NULL
,	NULL
143	NULL
+	NULL
55	NULL
%	NULL
:	NULL
P	NULL
<	NULL
0:001	NULL
)	NULL
.	NULL

The	NULL
data	NULL
also	NULL
demonstrate	NULL
that	NULL
addition	NULL
of	NULL
IL-2	NULL
restores	NULL
the	NULL
proliferative	NULL
capacity	NULL
of	NULL
anti-CD	NULL
?	NULL

-activated	NULL
neonatal	NULL
T	NULL
cells	NULL
to	NULL
adult	NULL
levels	NULL
similar	NULL
to	NULL
the	NULL
response	NULL
observed	NULL
with	NULL
anti-CD28	NULL
MoAb	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
proliferative	NULL
responses	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
exogenous	NULL
IL-2	NULL
were	NULL
greater	NULL
than	NULL
those	NULL
observed	NULL
when	NULL
anti-CD28	NULL
MoAb	NULL
was	NULL
present	NULL
as	NULL
costimulus	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Adult	NULL
Cord	NULL
AU	NULL
Unstim	NULL
0	NULL
0	NULL
CD2	NULL
75	NULL
11	NULL
CD2+28	NULL
98	NULL
86	NULL
CD28	NULL
25	NULL
5	NULL
(	NULL
b	NULL
)	NULL
Unstim	NULL
110	NULL
115	NULL
CD2	NULL
98	NULL
121	NULL
ang	NULL
125	NULL
131	NULL
avez	NULL
mome	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
on	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
.	NULL

T	NULL
cells	NULL
from	NULL
adults	NULL
and	NULL
neonates	NULL
were	NULL
cultured	NULL
for	NULL
18	NULL
h	NULL
alone	NULL
.	NULL

with	NULL
anti-CD2	NULL
,	NULL
anti-CD2	NULL
+	NULL
anti-CD28	NULL
MoAb	NULL
or	NULL
anti-CD28	NULL
MoAb	NULL
alone	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
and	NULL
blotted	NULL
onto	NULL
Hybond	NULL
N	NULL
+	NULL
membranes	NULL
.	NULL

IL-2	NULL
mRNA	NULL
(	NULL
a	NULL
)	NULL
and	NULL
F-actin	NULL
mRNA	NULL
(	NULL
b	NULL
)	NULL
were	NULL
detected	NULL
using	NULL
specific	NULL
cDNA	NULL
probes	NULL
as	NULL
described	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
arbitrary	NULL
units	NULL
(	NULL
AU	NULL
)	NULL
obtained	NULL
from	NULL
densitometric	NULL
analysis	NULL
.	NULL

A	NULL
representative	NULL
slot	NULL
blot	NULL
of	NULL
four	NULL
separate	NULL
experiments	NULL
is	NULL
shown	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
on	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
in	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
In	NULL
parallel	NULL
with	NULL
proliferation	NULL
and	NULL
IL-2	NULL
secretion	NULL
studies	NULL
,	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
was	NULL
also	NULL
investigated	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
a	NULL
representative	NULL
RNA	NULL
slot	NULL
blot	NULL
and	NULL
densitometric	NULL
analyses	NULL
are	NULL
©	NULL
1995	NULL
Blackwell	NULL
Science	NULL
Ltd.	NULL
C/imical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
102:192	NULL
198	NULL
196	NULL
J.	NULL
Hassan	NULL
et	NULL
al	NULL
.	NULL

kAd	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
on	NULL
NF	NULL
«	NULL
B	NULL
levels	NULL
is	NULL
shown	NULL
.	NULL

Purified	NULL
T	NULL
cells	NULL
were	NULL
unstimulated	NULL
,	NULL
or	NULL
stimulated	NULL
with	NULL
anti-CD2	NULL
,	NULL
anti-CD2	NULL
+	NULL
anti-CD28	NULL
MoAb	NULL
or	NULL
anti-CD28	NULL
MoAb	NULL
alone	NULL
for	NULL
2	NULL
h.	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
NFB	NULL
binding	NULL
activity	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Arrowheads	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
DNA-protein	NULL
complexes	NULL
.	NULL

Results	NULL
shown	NULL
are	NULL
representative	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

given	NULL
as	NULL
arbitrary	NULL
units	NULL
.	NULL

The	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
addition	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
to	NULL
T	NULL
cells	NULL
enhanced	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
mRNA	NULL
levels	NULL
in	NULL
both	NULL
groups	NULL
.	NULL

The	NULL
most	NULL
striking	NULL
observation	NULL
is	NULL
the	NULL
lack	NULL
of	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
in	NULL
anti-CD2-stimulated	NULL
cord	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
significantly	NULL
increased	NULL
the	NULL
expression	NULL
of	NULL
IL-2	NULL
transcript	NULL
to	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

Effect	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
on	NULL
NFKB	NULL
levels	NULL
Since	NULL
it	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
CD28-responsive	NULL
complex	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NFB	NULL
family	NULL
[	NULL
7,8	NULL
]	NULL
,	NULL
levels	NULL
of	NULL
NFB	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD2	NULL
and	NULL
anti-CD28	NULL
MoAb	NULL
for	NULL
2	NULL
h	NULL
were	NULL
examined	NULL
.	NULL

Figure	NULL
5	NULL
shows	NULL
NFB	NULL
levels	NULL
using	NULL
the	NULL
electrophoretic-mobility-shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

As	NULL
the	NULL
data	NULL
demonstrate	NULL
,	NULL
unstimulated	NULL
cells	NULL
or	NULL
cells	NULL
treated	NULL
with	NULL
anti-CD28	NULL
MoAb	NULL
alone	NULL
showed	NULL
low	NULL
levels	NULL
of	NULL
NFB	NULL
.	NULL

Anti-CD2	NULL
activation	NULL
induced	NULL
an	NULL
increase	NULL
in	NULL
NFkB	NULL
which	NULL
was	NULL
greatly	NULL
augmented	NULL
when	NULL
anti-CD28	NULL
MoAb	NULL
was	NULL
added	NULL
as	NULL
costimulus	NULL
to	NULL
the	NULL
cells	NULL
.	NULL

In	NULL
the	NULL
neonatal	NULL
T	NULL
cell	NULL
samples	NULL
,	NULL
NFxB	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
anti-CD2	NULL
stimulation	NULL
was	NULL
low	NULL
compared	NULL
with	NULL
adults	NULL
.	NULL

Although	NULL
addition	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
to	NULL
neonatal	NULL
cells	NULL
increased	NULL
NFkB	NULL
levels	NULL
,	NULL
it	NULL
was	NULL
not	NULL
restored	NULL
to	NULL
the	NULL
levels	NULL
observed	NULL
in	NULL
adults	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
CD2	NULL
and	NULL
CD28	NULL
on	NULL
neonatal	NULL
T	NULL
cell	NULL
Expression	NULL
of	NULL
the	NULL
CD28	NULL
antigen	NULL
on	NULL
five	NULL
neonatal	NULL
and	NULL
five	NULL
adult	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
was	NULL
examined	NULL
using	NULL
the	NULL
whole	NULL
blood	NULL
lysis	NULL
method	NULL
.	NULL

CD2	NULL
and	NULL
CD28	NULL
expression	NULL
was	NULL
found	NULL
to	NULL
be	NULL
similar	NULL
in	NULL
adults	NULL
(	NULL
AD	NULL
)	NULL
and	NULL
neonates	NULL
(	NULL
NB	NULL
)	NULL
(	NULL
MFI	NULL
+	NULL
s.e.m	NULL
.	NULL

:	NULL
CD2	NULL
,	NULL
NB	NULL
7345	NULL
+807	NULL
;	NULL
AD	NULL
7886	NULL
+713	NULL
;	NULL
CD28	NULL
,	NULL
NB	NULL
66-49	NULL
+	NULL
3-01	NULL
;	NULL
AD	NULL
64-06	NULL
+	NULL
3:50	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
staining	NULL
for	NULL
CD2	NULL
and	NULL
CD28	NULL
was	NULL
also	NULL
similar	NULL
in	NULL
adults	NULL
and	NULL
neonates	NULL
(	NULL
mean	NULL
+	NULL
s.e.m	NULL
.	NULL

:	NULL
CD2	NULL
,	NULL
NB	NULL
711	NULL
+	NULL
32	NULL
%	NULL
;	NULL
AD	NULL
751	NULL
+	NULL
08	NULL
%	NULL
;	NULL
CD28	NULL
,	NULL
NB	NULL
61-0	NULL
+	NULL
36	NULL
%	NULL
;	NULL
AD	NULL
63-2	NULL
+	NULL
1+2	NULL
%	NULL
)	NULL
.	NULL

DISCUSSION	NULL
The	NULL
experiments	NULL
described	NULL
here	NULL
demonstrate	NULL
that	NULL
activation	NULL
via	NULL
the	NULL
CD28	NULL
cell	NULL
surface	NULL
molecule	NULL
provides	NULL
a	NULL
potent	NULL
amplification	NULL
signal	NULL
for	NULL
neonatal	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Anti-CD2-stimulated	NULL
neonatal	NULL
T	NULL
cells	NULL
showed	NULL
greater	NULL
augmentation	NULL
of	NULL
responses	NULL
as	NULL
observed	NULL
by	NULL
proliferative	NULL
capacity	NULL
,	NULL
IL-2	NULL
production	NULL
,	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
and	NULL
NFB	NULL
levels	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
compared	NULL
with	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
the	NULL
CD2	NULL
pathway	NULL
of	NULL
T	NULL
cell	NULL
activation	NULL
functions	NULL
as	NULL
an	NULL
early	NULL
thymocyte	NULL
proliferative	NULL
signal	NULL
,	NULL
since	NULL
human	NULL
CD2	NULL
is	NULL
expressed	NULL
early	NULL
in	NULL
thymic	NULL
ontogeny	NULL
before	NULL
expression	NULL
of	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
[	NULL
22	NULL
]	NULL
.	NULL

Phenotypic	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
neonatal	NULL
T	NULL
cells	NULL
are	NULL
similar	NULL
to	NULL
recent	NULL
emigrants	NULL
from	NULL
the	NULL
thymus	NULL
.	NULL

Nearly	NULL
all	NULL
T	NULL
cells	NULL
from	NULL
neonates	NULL
express	NULL
the	NULL
thymocyte	NULL
surface	NULL
antigens	NULL
,	NULL
CD10	NULL
and	NULL
CD38	NULL
[	NULL
23,24	NULL
]	NULL
.	NULL

Furthermore	NULL
,	NULL
similar	NULL
to	NULL
mature	NULL
thymocytes	NULL
,	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
express	NULL
the	NULL
high	NULL
molecular	NULL
weight	NULL
isoform	NULL
of	NULL
the	NULL
CD45	NULL
molecule	NULL
,	NULL
as	NULL
identified	NULL
by	NULL
antibodies	NULL
to	NULL
CD4SRA	NULL
[	NULL
25	NULL
]	NULL
.	NULL

Evidence	NULL
suggests	NULL
that	NULL
the	NULL
CD45RA	NULL
subset	NULL
of	NULL
T	NULL
cells	NULL
is	NULL
antigenically	NULL
naive	NULL
,	NULL
and	NULL
we	NULL
have	NULL
further	NULL
proposed	NULL
that	NULL
neonatal	NULL
naive	NULL
T	NULL
cells	NULL
are	NULL
precursors	NULL
of	NULL
adult	NULL
naive	NULL
T	NULL
cells	NULL
[	NULL
26	NULL
]	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
in	NULL
contrast	NULL
to	NULL
peripheral	NULL
blood	NULL
adult	NULL
T	NULL
cells	NULL
,	NULL
thymocytes	NULL
are	NULL
unable	NULL
to	NULL
proliferate	NULL
in	NULL
response	NULL
to	NULL
CD2	NULL
stimulation	NULL
[	NULL
27	NULL
]	NULL
.	NULL

Similarly	NULL
,	NULL
we	NULL
and	NULL
others	NULL
in	NULL
in	NULL
vitro	NULL
studies	NULL
of	NULL
neonatal	NULL
T	NULL
cell	NULL
responses	NULL
have	NULL
demonstrated	NULL
deficient	NULL
responses	NULL
to	NULL
antibodies	NULL
that	NULL
activate	NULL
signalling	NULL
through	NULL
the	NULL
CD2	NULL
molecule	NULL
[	NULL
15,28	NULL
]	NULL
.	NULL

Anti-CD2	NULL
stimulation	NULL
of	NULL
adult	NULL
T	NULL
cells	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
a	NULL
proliferative	NULL
response	NULL
.	NULL

However	NULL
,	NULL
anti-CD2	NULL
stimulation	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
deficient	NULL
proliferative	NULL
response	NULL
.	NULL

Furthermore	NULL
,	NULL
although	NULL
anti-CD2	NULL
stimulation	NULL
is	NULL
a	NULL
poor	NULL
inducer	NULL
of	NULL
IL-2	NULL
production	NULL
,	NULL
the	NULL
results	NULL
reported	NULL
here	NULL
indicate	NULL
that	NULL
neonatal	NULL
T	NULL
cell	NULL
induction	NULL
of	NULL
IL-2	NULL
is	NULL
significantly	NULL
lower	NULL
than	NULL
adult	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
contributes	NULL
to	NULL
the	NULL
reduced	NULL
proliferative	NULL
response	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
finding	NULL
that	NULL
supplementation	NULL
of	NULL
neonatal	NULL
T	NULL
cell	NULL
cultures	NULL
with	NULL
IL-2	NULL
restores	NULL
the	NULL
proliferative	NULL
capabilities	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
neonatal	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
activated	NULL
through	NULL
the	NULL
CD2	NULL
molecule	NULL
,	NULL
although	NULL
they	NULL
appear	NULL
to	NULL
require	NULL
exogenous	NULL
IL-2	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
proliferative	NULL
responses	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

Other	NULL
investigators	NULL
have	NULL
reported	NULL
that	NULL
expression	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
is	NULL
comparable	NULL
in	NULL
neonatal	NULL
and	NULL
adult	NULL
T	NULL
cells	NULL
[	NULL
29	NULL
]	NULL
.	NULL

Addition	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
greatly	NULL
augmented	NULL
IL-2	NULL
secretion	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
,	NULL
but	NULL
this	NULL
was	NULL
still	NULL
less	NULL
than	NULL
the	NULL
IL-2	NULL
levels	NULL
elicited	NULL
by	NULL
adult	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
limited	NULL
capacity	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
to	NULL
secrete	NULL
IL-2	NULL
may	NULL
indicate	NULL
that	NULL
these	NULL
cells	NULL
have	NULL
further	NULL
activation	NULL
requirements	NULL
for	NULL
the	NULL
elicitation	NULL
of	NULL
a	NULL
comparable	NULL
response	NULL
to	NULL
adults	NULL
,	NULL
although	NULL
phenotypically	NULL
©	NULL
1995	NULL
Blackweli	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
102:192-198	NULL
CD28	NULL
signalling	NULL
of	NULL
human	NULL
naive	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
197	NULL
neonatal	NULL
T	NULL
cells	NULL
are	NULL
similar	NULL
to	NULL
adult	NULL
T	NULL
cells	NULL
with	NULL
regard	NULL
to	NULL
CD2	NULL
and	NULL
CD28	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
increasing	NULL
IL-2	NULL
mRNA	NULL
stability	NULL
,	NULL
recent	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
signalling	NULL
via	NULL
CD28	NULL
caused	NULL
transcrip-tional	NULL
activation	NULL
by	NULL
binding	NULL
to	NULL
the	NULL
CD28-responsive	NULL
element	NULL
in	NULL
the	NULL
IL-2	NULL
enhancer	NULL
region	NULL
[	NULL
7,8	NULL
]	NULL
.	NULL

The	NULL
IL-2	NULL
CD28-responsive	NULL
complex	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
members	NULL
of	NULL
the	NULL
NFB	NULL
family	NULL
[	NULL
7,8	NULL
]	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
demonstration	NULL
that	NULL
costimulation	NULL
of	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
with	NULL
anti-CD2	NULL
and	NULL
anti-CD28	NULL
increases	NULL
NFxB	NULL
levels	NULL
.	NULL

The	NULL
study	NULL
by	NULL
Verweij	NULL
et	NULL
al	NULL
.	NULL

[	NULL
7	NULL
]	NULL
examined	NULL
the	NULL
Jurkat	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
whereas	NULL
Ghosh	NULL
et	NULL
a/	NULL
.	NULL

[	NULL
8	NULL
]	NULL
examined	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
and	NULL
anti-CD28	NULL
MoAb	NULL
.	NULL

Anti-CD2	NULL
alone	NULL
induces	NULL
lower	NULL
NFB	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
hence	NULL
minimal	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

Although	NULL
costimulation	NULL
with	NULL
anti-CD28	NULL
MoAb	NULL
increases	NULL
NFB	NULL
levels	NULL
in	NULL
the	NULL
nuclear	NULL
extracts	NULL
of	NULL
cord	NULL
T	NULL
cells	NULL
,	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
adults	NULL
were	NULL
not	NULL
achieved	NULL
.	NULL

NFB	NULL
activity	NULL
is	NULL
related	NULL
to	NULL
the	NULL
maturational	NULL
stage	NULL
of	NULL
the	NULL
cell	NULL
and	NULL
is	NULL
developmentally	NULL
regulated	NULL
[	NULL
30	NULL
]	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
low	NULL
levels	NULL
of	NULL
inducible	NULL
NFB	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
shown	NULL
in	NULL
this	NULL
study	NULL
provides	NULL
further	NULL
evidence	NULL
of	NULL
their	NULL
imma-turity	NULL
.	NULL

Whether	NULL
there	NULL
is	NULL
any	NULL
link	NULL
between	NULL
the	NULL
lower	NULL
NFB	NULL
levels	NULL
and	NULL
IL-2	NULL
produced	NULL
in	NULL
neonatal	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
costimulation	NULL
remains	NULL
unclear	NULL
.	NULL

However	NULL
,	NULL
recent	NULL
data	NULL
have	NULL
shown	NULL
that	NULL
concentrations	NULL
of	NULL
inducible	NULL
transcription	NULL
factors	NULL
are	NULL
a	NULL
major	NULL
component	NULL
of	NULL
the	NULL
regulatory	NULL
mechanisms	NULL
which	NULL
dictate	NULL
differential	NULL
IL-2	NULL
expression	NULL
in	NULL
T	NULL
cell	NULL
subsets	NULL
[	NULL
31	NULL
]	NULL
.	NULL

Previous	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
neonatal	NULL
T	NULL
cells	NULL
have	NULL
deficient	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
[	NULL
11,32	NULL
]	NULL
.	NULL

Because	NULL
the	NULL
vast	NULL
majority	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
are	NULL
of	NULL
the	NULL
naive	NULL
CD45RA	NULL
phenotype	NULL
,	NULL
we	NULL
suggest	NULL
the	NULL
following	NULL
scenario	NULL
.	NULL

All	NULL
naive	NULL
T	NULL
lymphocytes	NULL
appear	NULL
to	NULL
require	NULL
a	NULL
signal	NULL
from	NULL
another	NULL
cell	NULL
in	NULL
order	NULL
to	NULL
proliferate	NULL
,	NULL
and	NULL
this	NULL
proliferative	NULL
response	NULL
is	NULL
the	NULL
necessary	NULL
precursor	NULL
to	NULL
mounting	NULL
an	NULL
adequate	NULL
immune	NULL
response	NULL
.	NULL

When	NULL
these	NULL
same	NULL
T	NULL
lymphocytes	NULL
bind	NULL
antigen	NULL
without	NULL
receiving	NULL
the	NULL
necessary	NULL
costimulatory	NULL
signals	NULL
they	NULL
become	NULL
anergic	NULL
.	NULL

Recent	NULL
studies	NULL
have	NULL
suggested	NULL
that	NULL
CD28	NULL
may	NULL
act	NULL
as	NULL
a	NULL
switch	NULL
between	NULL
anergy	NULL
and	NULL
activation	NULL
[	NULL
16	NULL
]	NULL
.	NULL

Our	NULL
findings	NULL
show	NULL
that	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
surface	NULL
molecules	NULL
CD2	NULL
and	NULL
CD28	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
expansion	NULL
and	NULL
further	NULL
differentiation	NULL
of	NULL
neonatal	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
since	NULL
IL-2	NULL
production	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD28	NULL
MoAb	NULL
was	NULL
still	NULL
lower	NULL
than	NULL
in	NULL
adults	NULL
,	NULL
expansion	NULL
and	NULL
recruitment	NULL
of	NULL
T	NULL
cells	NULL
perhaps	NULL
to	NULL
an	NULL
antigenic	NULL
challenge	NULL
may	NULL
result	NULL
in	NULL
a	NULL
delayed	NULL
response	NULL
.	NULL

Such	NULL
a	NULL
delayed	NULL
T	NULL
cell	NULL
response	NULL
to	NULL
herpes	NULL
virus	NULL
group	NULL
antigens	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
neonates	NULL
when	NULL
compared	NULL
with	NULL
non-immune	NULL
adults	NULL
[	NULL
32	NULL
]	NULL
.	NULL

T	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
development	NULL
and	NULL
in	NULL
different	NULL
cytokine	NULL
environments	NULL
have	NULL
different	NULL
costimulation	NULL
requirements	NULL
which	NULL
may	NULL
influence	NULL
the	NULL
distinctive	NULL
response	NULL
that	NULL
occurs	NULL
.	NULL

However	NULL
,	NULL
CD28	NULL
may	NULL
not	NULL
be	NULL
the	NULL
entire	NULL
story	NULL
in	NULL
the	NULL
neonate	NULL
,	NULL
where	NULL
various	NULL
other	NULL
molecules	NULL
may	NULL
have	NULL
significant	NULL
roles	NULL
.	NULL

Evidence	NULL
for	NULL
this	NULL
comes	NULL
from	NULL
a	NULL
study	NULL
which	NULL
shows	NULL
that	NULL
mice	NULL
lacking	NULL
CD28	NULL
,	NULL
while	NULL
significantly	NULL
compromised	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
mount	NULL
adaptive	NULL
immune	NULL
responses	NULL
,	NULL
are	NULL
not	NULL
totally	NULL
immunodeficient	NULL
[	NULL
33	NULL
]	NULL
.	NULL

This	NULL
may	NULL
reflect	NULL
other	NULL
pathways	NULL
of	NULL
costimulation	NULL
of	NULL
naive	NULL
neonatal	NULL
T	NULL
cells	NULL
which	NULL
remain	NULL
to	NULL
be	NULL
studied	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
wish	NULL
to	NULL
thank	NULL
the	NULL
nursing	NULL
staff	NULL
of	NULL
the	NULL
Coombe	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
Dublin	NULL
,	NULL
for	NULL
collecting	NULL
cord	NULL
blood	NULL
samples	NULL
.	NULL

REFERENCES	NULL
Schwartz	NULL
RH	NULL
.	NULL

A	NULL
cell	NULL
culture	NULL
model	NULL
for	NULL
T	NULL
lymphocyte	NULL
clonal	NULL
anergy	NULL
.	NULL

Science	NULL
1990	NULL
;	NULL
248:1	NULL
349-56	NULL
.	NULL

2	NULL
Lin	NULL
Y	NULL
,	NULL
Janeway	NULL
CA	NULL
.	NULL

Interferon	NULL
gamma	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
induced	NULL
cell	NULL
death	NULL
of	NULL
effector	NULL
T	NULL
cell	NULL
:	NULL
a	NULL
possible	NULL
third	NULL
mechanism	NULL
of	NULL
self-tolerance	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1990	NULL
;	NULL
172:1735-9	NULL
.	NULL

June	NULL
CH	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Linsley	NULL
PS	NULL
,	NULL
Thompson	NULL
CD	NULL
.	NULL

Role	NULL
of	NULL
CD28	NULL
receptor	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Immunol	NULL
Today	NULL
1990	NULL
;	NULL
11:211-6	NULL
.	NULL

4	NULL
June	NULL
CH	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Lindsten	NULL
T	NULL
,	NULL
Thompson	NULL
CD	NULL
.	NULL

Evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
three	NULL
distinct	NULL
signals	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

J	NULL
Immunol	NULL
1989	NULL
;	NULL
143:153-61	NULL
.	NULL

Lindsten	NULL
T	NULL
,	NULL
June	NULL
CH	NULL
,	NULL
Ledbetter	NULL
JA	NULL
,	NULL
Stella	NULL
G	NULL
,	NULL
Thompson	NULL
CD	NULL
.	NULL

Regulation	NULL
of	NULL
lymphokine	NULL
mRNA	NULL
stability	NULL
by	NULL
a	NULL
surface-mediated	NULL
T	NULL
cell	NULL
activation	NULL
pathway	NULL
.	NULL

Science	NULL
1989	NULL
;	NULL
244:339-43	NULL
.	NULL

6	NULL
Fraser	NULL
JD	NULL
,	NULL
Irving	NULL
BA	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Weiss	NULL
A	NULL
.	NULL

Regulation	NULL
of	NULL
IL-2	NULL
gene	NULL
enhancer	NULL
activity	NULL
by	NULL
the	NULL
T	NULL
cell	NULL
accessory	NULL
molecule	NULL
CD28	NULL
.	NULL

Science	NULL
1991	NULL
;	NULL
251:313-6	NULL
.	NULL

7	NULL
Verweij	NULL
CL	NULL
,	NULL
Geerts	NULL
M	NULL
,	NULL
Aarden	NULL
LA	NULL
.	NULL

Activation	NULL
of	NULL
interleukin-2	NULL
gene	NULL
transcription	NULL
via	NULL
the	NULL
T	NULL
cell	NULL
surface	NULL
molecule	NULL
CD28	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
NF	NULL
<	NULL
B-like	NULL
response	NULL
element	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
1991	NULL
;	NULL
266:14179-82	NULL
.	NULL

8	NULL
Ghosh	NULL
P	NULL
,	NULL
Tan	NULL
T-H	NULL
,	NULL
Rice	NULL
NR	NULL
,	NULL
Sica	NULL
A	NULL
,	NULL
Young	NULL
HA	NULL
.	NULL

The	NULL
interleukin-2	NULL
CD28-responsive	NULL
complex	NULL
contains	NULL
at	NULL
least	NULL
three	NULL
members	NULL
of	NULL
the	NULL
NF	NULL
«	NULL
B	NULL
family	NULL
:	NULL
c-rel	NULL
p	NULL
50	NULL
and	NULL
p	NULL
65	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
1993	NULL
;	NULL
90:1696-1700	NULL
.	NULL

9	NULL
Thompson	NULL
CB	NULL
,	NULL
Lindsten	NULL
T	NULL
,	NULL
Ledbetter	NULL
JA	NULL
er	NULL
al	NULL
.	NULL

CD28	NULL
activation	NULL
pathway	NULL
regulates	NULL
the	NULL
production	NULL
of	NULL
multiple	NULL
T	NULL
cell	NULL
derived	NULL
lymphokines/cytokines	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
1989	NULL
;	NULL
86	NULL
:	NULL
1333-7	NULL
.	NULL

10	NULL
FairFax	NULL
CA	NULL
,	NULL
Borzy	NULL
MS	NULL
.	NULL

Interleukin-2	NULL
production	NULL
,	NULL
proliferative	NULL
response	NULL
,	NULL
and	NULL
receptor	NULL
expression	NULL
by	NULL
cord	NULL
mononuclear	NULL
cells	NULL
.	NULL

J	NULL
Clin	NULL
Lab	NULL
Immunol	NULL
1988	NULL
;	NULL
27:63-67	NULL
.	NULL

11	NULL
Wilson	NULL
CB	NULL
.	NULL

Immunologic	NULL
basis	NULL
for	NULL
increased	NULL
susceptibility	NULL
of	NULL
the	NULL
neonate	NULL
to	NULL
infection	NULL
.	NULL

J	NULL
Pediatr	NULL
1986	NULL
;	NULL
108:1-12	NULL
.	NULL

12	NULL
Splawski	NULL
JB	NULL
,	NULL
Jelinek	NULL
DF	NULL
,	NULL
Lipsky	NULL
PE	NULL
.	NULL

Delineation	NULL
of	NULL
the	NULL
functional	NULL
capacity	NULL
of	NULL
human	NULL
neonatal	NULL
lymphocytes	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
1991	NULL
;	NULL
87:545-53	NULL
.	NULL

13	NULL
Watson	NULL
W	NULL
,	NULL
Oen	NULL
K	NULL
,	NULL
Ramdahin	NULL
R	NULL
,	NULL
Harman	NULL
C.	NULL
Immunoglobulin	NULL
and	NULL
cytokine	NULL
production	NULL
by	NULL
neonatal	NULL
lymphocytes	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
1991	NULL
;	NULL
83:169-74	NULL
.	NULL

14	NULL
Gauchat	NULL
JF	NULL
,	NULL
Gauchat	NULL
D	NULL
,	NULL
DeWeck	NULL
Al	NULL
,	NULL
Stadler	NULL
BM	NULL
.	NULL

Cytokine	NULL
mRNA	NULL
levels	NULL
in	NULL
antigen-stimulated	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
1989	NULL
;	NULL
19:1079-85	NULL
.	NULL

15	NULL
Hassan	NULL
J	NULL
,	NULL
Reen	NULL
DJ	NULL
.	NULL

Interleukin-1	NULL
augments	NULL
the	NULL
diminished	NULL
IL-2	NULL
mRNA	NULL
expression	NULL
and	NULL
proliferative	NULL
response	NULL
of	NULL
neonatal	NULL
T	NULL
lymphocytes	NULL
to	NULL
anti-CD2	NULL
antibodies	NULL
.	NULL

Scand	NULL
J	NULL
Immunol	NULL
1994	NULL
;	NULL
39:597-601	NULL
.	NULL

16	NULL
Harding	NULL
FA	NULL
,	NULL
McArthur	NULL
JF	NULL
,	NULL
Gross	NULL
JA	NULL
,	NULL
Raulet	NULL
DH	NULL
,	NULL
Allison	NULL
JP	NULL
.	NULL

CD28-mediated	NULL
signaling	NULL
co-stimulates	NULL
murine	NULL
T	NULL
cells	NULL
and	NULL
prevents	NULL
induction	NULL
of	NULL
anergy	NULL
in	NULL
T	NULL
cell	NULL
clones	NULL
.	NULL

Nature	NULL
1992	NULL
;	NULL
356:607-9	NULL
.	NULL

17	NULL
Wesselborg	NULL
S	NULL
,	NULL
Prufer	NULL
U	NULL
,	NULL
Wild	NULL
M	NULL
,	NULL
Schraven	NULL
B	NULL
,	NULL
Meuer	NULL
SC	NULL
,	NULL
Kabelitz	NULL
D.	NULL
Triggering	NULL
via	NULL
the	NULL
alternative	NULL
CD2	NULL
pathway	NULL
induces	NULL
apoptosis	NULL
in	NULL
activated	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
1993	NULL
;	NULL
23:2707-10	NULL
.	NULL

18	NULL
Julius	NULL
MH	NULL
,	NULL
Simpson	NULL
E	NULL
,	NULL
Herzenberg	NULL
LA	NULL
.	NULL

A	NULL
rapid	NULL
method	NULL
for	NULL
isolation	NULL
of	NULL
functional	NULL
thymus-derived	NULL
murine	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
1973	NULL
;	NULL
3:645-9	NULL
.	NULL

19	NULL
Sambrook	NULL
J	NULL
,	NULL
Fritsch	NULL
EF	NULL
,	NULL
Maniatis	NULL
T.	NULL
A	NULL
laboratory	NULL
manual	NULL
.	NULL

New	NULL
York	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbour	NULL
Laboratory	NULL
Press	NULL
,	NULL
1989	NULL
.	NULL

20	NULL
Osborn	NULL
L	NULL
,	NULL
Kunkel	NULL
S	NULL
,	NULL
Nabel	NULL
GJ	NULL
.	NULL

TNFa	NULL
and	NULL
IL-1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B.	NULL
Proc	NULL
Nati	NULL
Acad	NULL
Sci	NULL
USA	NULL
1989	NULL
;	NULL
86:2336-10	NULL
.	NULL

Moynagh	NULL
PN	NULL
,	NULL
Williams	NULL
DC	NULL
,	NULL
O'Neill	NULL
LAJ	NULL
.	NULL

Interleukin-1	NULL
activated	NULL
transcription	NULL
factor	NULL
NF	NULL
xB	NULL
in	NULL
glial	NULL
cells	NULL
.	NULL

Biochem	NULL
J	NULL
1993	NULL
;	NULL
294:343-	NULL
7	NULL
.	NULL

22	NULL
Bierer	NULL
BE	NULL
,	NULL
Sleckman	NULL
BP	NULL
,	NULL
Ratnofsky	NULL
SE	NULL
,	NULL
Burakoff	NULL
SJ	NULL
.	NULL

The	NULL
biologic	NULL
to	NULL
tn	NULL
2	NULL
st	NULL
©	NULL
1995	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
102:192-198	NULL
198	NULL
23	NULL
24	NULL
25	NULL
26	NULL
27	NULL
28	NULL
roles	NULL
of	NULL
CD2	NULL
,	NULL
CD4	NULL
and	NULL
CD8	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Ann	NULL
Rev	NULL
Immunol	NULL
1989	NULL
;	NULL
7:579-99	NULL
.	NULL

Gerli	NULL
R	NULL
,	NULL
Rambotti	NULL
P	NULL
,	NULL
Cernetti	NULL
C	NULL
,	NULL
Verlardi	NULL
A	NULL
,	NULL
Spinozzi	NULL
F.	NULL
Evidence	NULL
for	NULL
phenotypic	NULL
T-precursor	NULL
cells	NULL
in	NULL
human	NULL
cord	NULL
blood	NULL
.	NULL

Brit	NULL
J	NULL
Haematol	NULL
1983	NULL
;	NULL
53:68	NULL
5-6	NULL
.	NULL

Griffith-Chu	NULL
S	NULL
,	NULL
Patterson	NULL
JAK	NULL
,	NULL
Berger	NULL
CI	NULL
,	NULL
Edelson	NULL
RI	NULL
,	NULL
Chu	NULL
AC	NULL
.	NULL

Characterization	NULL
of	NULL
immature	NULL
T	NULL
cell	NULL
subpopulations	NULL
in	NULL
neonatal	NULL
blood	NULL
.	NULL

Blood	NULL
1984	NULL
;	NULL
64:296-300	NULL
.	NULL

Hannet	NULL
I	NULL
,	NULL
Erkeller-Yuksel	NULL
F	NULL
,	NULL
Lydyard	NULL
P	NULL
,	NULL
Deneys	NULL
V	NULL
,	NULL
DeBruyere	NULL
M.	NULL
Developmental	NULL
and	NULL
maturational	NULL
changes	NULL
in	NULL
human	NULL
blood	NULL
lymphocyte	NULL
subpopulations	NULL
.	NULL

Immunol	NULL
Today	NULL
1992	NULL
;	NULL
13:215-8	NULL
.	NULL

Hassan	NULL
J	NULL
,	NULL
Reen	NULL
DJ	NULL
.	NULL

Neonatal	NULL
CD4*	NULL
CD4SRA	NULL
*	NULL
T	NULL
cells	NULL
:	NULL
precursors	NULL
of	NULL
adult	NULL
CD4*	NULL
CD45SRA	NULL
*	NULL
T	NULL
cells	NULL
?	NULL

Res	NULL
Immunol	NULL
1993	NULL
;	NULL
144:87-92	NULL
.	NULL

Yang	NULL
SY	NULL
,	NULL
Denning	NULL
SM	NULL
,	NULL
Mizuno	NULL
S	NULL
,	NULL
Dupont	NULL
B	NULL
,	NULL
Haynes	NULL
BF	NULL
.	NULL

A	NULL
novel	NULL
activation	NULL
pathway	NULL
for	NULL
mature	NULL
thymocytes	NULL
.	NULL

Costimulation	NULL
of	NULL
CD2	NULL
and	NULL
CD28	NULL
induces	NULL
autocrine	NULL
interleukin-2/interleukin-2	NULL
receptor-mediated	NULL
cell	NULL
proliferation	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
1988	NULL
;	NULL
168:1457-68	NULL
.	NULL

Gerli	NULL
R	NULL
,	NULL
Bertotto	NULL
A	NULL
,	NULL
Crupi	NULL
S	NULL
et	NULL
al	NULL
.	NULL

Activation	NULL
of	NULL
cord	NULL
T	NULL
lympho-cytes-evidence	NULL
for	NULL
a	NULL
defective	NULL
T	NULL
cell	NULL
mitogenesis	NULL
induced	NULL
through	NULL
the	NULL
CD2	NULL
molecule	NULL
.	NULL

J	NULL
Immunol	NULL
1989	NULL
;	NULL
142:2583-9	NULL
.	NULL

29	NULL
30	NULL
31	NULL
32	NULL
33	NULL
J.	NULL
Hassan	NULL
et	NULL
al	NULL
.	NULL

Wilson	NULL
CB	NULL
,	NULL
Westall	NULL
L	NULL
,	NULL
Johnson	NULL
L	NULL
,	NULL
Lewis	NULL
DB	NULL
,	NULL
Dower	NULL
SK	NULL
,	NULL
Alpert	NULL
AR	NULL
.	NULL

Decreased	NULL
production	NULL
of	NULL
interferon-gamma	NULL
by	NULL
human	NULL
neonatal	NULL
cells	NULL
,	NULL
intrinsic	NULL
and	NULL
regulatory	NULL
deficiencies	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
1986	NULL
;	NULL
77:860-7	NULL
.	NULL

Ullman	NULL
KS	NULL
,	NULL
Northorp	NULL
JP	NULL
,	NULL
Verweij	NULL
C1	NULL
,	NULL
Crabtree	NULL
GR	NULL
.	NULL

Transmission	NULL
of	NULL
signals	NULL
from	NULL
the	NULL
T	NULL
lymphocyte	NULL
antigens	NULL
receptor	NULL
to	NULL
the	NULL
genes	NULL
responsible	NULL
for	NULL
cell	NULL
proliferation	NULL
and	NULL
immune	NULL
function	NULL
:	NULL
the	NULL
missing	NULL
link	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
1990	NULL
;	NULL
8:421-52	NULL
.	NULL

Barve	NULL
SS	NULL
,	NULL
Cohen	NULL
DA	NULL
,	NULL
De	NULL
Benedetti	NULL
A	NULL
,	NULL
Rhoads	NULL
RE	NULL
,	NULL
Kaplan	NULL
AM	NULL
.	NULL

Mechanism	NULL
of	NULL
differential	NULL
regulation	NULL
of	NULL
IL-2	NULL
in	NULL
murine	NULL
Th1	NULL
and	NULL
Th2	NULL
T	NULL
cell	NULL
subsets	NULL
.	NULL

1	NULL
.	NULL

Induction	NULL
of	NULL
IL-2	NULL
transcription	NULL
in	NULL
Th2	NULL
cells	NULL
by	NULL
up-regulation	NULL
of	NULL
transcription	NULL
factor	NULL
with	NULL
the	NULL
protein	NULL
synthesis	NULL
initiation	NULL
factor	NULL
4E	NULL
.	NULL

J	NULL
Immunol	NULL
1994	NULL
;	NULL
152:1171-81	NULL
.	NULL

Chilmonezyk	NULL
BA	NULL
,	NULL
Levin	NULL
MJ	NULL
,	NULL
McDuffy	NULL
R	NULL
,	NULL
Hayward	NULL
AR	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
newborn	NULL
response	NULL
to	NULL
herpesvirus	NULL
antigen	NULL
.	NULL

J	NULL
Immunol	NULL
1985	NULL
;	NULL
134:4184-8	NULL
.	NULL

Shahinian	NULL
A	NULL
,	NULL
Pfeffer	NULL
K	NULL
,	NULL
Lee	NULL
KP	NULL
et	NULL
a/	NULL
.	NULL

Differential	NULL
T	NULL
cell	NULL
costimulatory	NULL
requirements	NULL
in	NULL
CD28-deficient	NULL
mice	NULL
.	NULL

Science	NULL
1993	NULL
;	NULL
261:609-12	NULL
.	NULL

©	NULL
1995	NULL
Blackwell	NULL
Science	NULL
Ltd	NULL
,	NULL
Clinical	NULL
and	NULL
Experimental	NULL
Immunology	NULL
,	NULL
102:192-198	NULL

